Literature DB >> 7835383

The epidemiology of migraine.

R B Lipton1, W F Stewart.   

Abstract

To obtain accurate estimates of migraine prevalence, population-based studies are required. Clinic-based studies include a highly selected group of migraine sufferers. Even in population-based studies, there have been wide variations in estimates of migraine prevalence. A meta-analysis has shown that age, gender and case definition account for 70% of this variance. Recent studies using International Headache Society (IHS) diagnostic criteria have given relatively consistent estimates of migraine prevalence (about 15-18% of women and 6% of men) and indicate that migraine occurs most commonly in men and women aged 25-55 years. Migraine is a heterogeneous condition with a spectrum of severity and associated disability, and it is under-diagnosed worldwide.

Entities:  

Mesh:

Year:  1994        PMID: 7835383     DOI: 10.1159/000119525

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  15 in total

Review 1.  Practical considerations for the treatment of elderly patients with migraine.

Authors:  Paola Sarchielli; Maria Luisa Mancini; Paolo Calabresi
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 2.  Headache.

Authors:  John E Jordan
Journal:  AJNR Am J Neuroradiol       Date:  2007-10       Impact factor: 3.825

Review 3.  Pharmacological targeting of spreading depression in migraine.

Authors:  Katharina Eikermann-Haerter; Anil Can; Cenk Ayata
Journal:  Expert Rev Neurother       Date:  2012-03       Impact factor: 4.618

Review 4.  Sumatriptan. A pharmacoeconomic review of its use in migraine.

Authors:  A J Coukell; H M Lamb
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

Review 5.  Burden of migraine. A review of its socioeconomic impact.

Authors:  G D Solomon; K L Price
Journal:  Pharmacoeconomics       Date:  1997       Impact factor: 4.981

Review 6.  Frovatriptan.

Authors:  S E Easthope; K L Goa
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 7.  Classical diseases revisited: transient global amnesia.

Authors:  D Owen; B Paranandi; R Sivakumar; M Seevaratnam
Journal:  Postgrad Med J       Date:  2007-04       Impact factor: 2.401

8.  Systemic right-to-left shunts, ischemic brain lesions, and persistent migraine activity.

Authors:  Hille Koppen; Inge H Palm-Meinders; Werner H Mess; Ruud W Keunen; Gisela M Terwindt; Lenore J Launer; Mark A van Buchem; Mark C Kruit; Michel D Ferrari
Journal:  Neurology       Date:  2016-03-11       Impact factor: 9.910

9.  Preventive pharmacologic treatments for episodic migraine in adults.

Authors:  Tatyana A Shamliyan; Jae-Young Choi; Rema Ramakrishnan; Jennifer Biggs Miller; Shi-Yi Wang; Frederick R Taylor; Robert L Kane
Journal:  J Gen Intern Med       Date:  2013-04-17       Impact factor: 5.128

10.  The burden of migraine in Spain: beyond direct costs.

Authors:  Xavier Badia; Sol Magaz; Laura Gutiérrez; Jordi Galván
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.